Stock listing
Stuttgart:VX1 Vertex Pharmaceuticals Incorporated Aktie
German listing (Stuttgart) of Vertex Pharmaceuticals Incorporated · home listing NASDAQ:VRTX
Follow Vertex Pharmaceuticals Incorporated into a list and get an email when it puts out news.
Home listing price · NASDAQ:VRTX
$558.88 USD +18.88 (+3.5%)
Close on Oct 30, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:VRTX
- Day range
- $549.89 – $563.80 USDOct 30, 2026
- Volume
- 2.88M sharesOct 30, 2026
- Market cap
- $141.7B USDAt the close on Oct 30, 2026 · price × 253.5M shares outstanding
- 52-week range
- $403.16 – $563.80 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $617.0M USDMedian day 1.06M shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:VRTX · Home | $558.88 USD | +18.88 (+3.5%) | 2,882,050 | $550.73 | $563.80 | $549.89 | $540.00 | Close on Oct 30, 2026 |
| BMV:VRTX | $10,032 MXN | +666 (+7.1%) | 8 | $10,032 | $10,032 | $10,032 | $9,366.49 | Close on Oct 22, 2026 |
| B3:VRTX34 | 82.80 BRL | -1.52 (-1.8%) | 23 | 82.56 | 82.80 | 82.56 | 84.32 | Close on Oct 23, 2026 |
| LSE:0QZU | $518.30 USD | -7.43 (-1.4%) | 463 | $514.25 | $524.87 | $505.56 | $525.73 | Close on Oct 27, 2026 |
| Frankfurt:VX1 | €500.50 EUR | +31.70 (+6.8%) | 174 | €486.20 | €500.50 | €486.20 | €468.80 | Close on Oct 30, 2026 |
| Dusseldorf:VX1 | €499.75 EUR | +36.95 (+8.0%) | — | €487.50 | €500.10 | €487.50 | €462.80 | Close on Oct 30, 2026 |
| Munich:VX1 | €464.55 EUR | -11.30 (-2.4%) | — | €464.55 | €464.55 | €464.55 | €475.85 | Close on Oct 27, 2026 |
| Hamburg:VX1 | €500.90 EUR | +39.75 (+8.6%) | — | €488.00 | €500.90 | €488.00 | €461.15 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:VRTX · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $558.88 | +18.88 | +3.5% | $550.73 | $563.80 | $549.89 | 2,882,050 | |
| $540.00 | +10.31 | +1.9% | $536.46 | $546.60 | $534.02 | 1,536,463 | |
| $529.69 | +8.66 | +1.7% | $514.45 | $534.94 | $513.37 | 1,240,906 | |
| $521.03 | +3.54 | +0.7% | $514.84 | $521.43 | $509.21 | 1,019,510 | |
| $517.49 | -6.44 | -1.2% | $526.86 | $529.66 | $509.33 | 1,143,037 | |
| $523.93 | -11.24 | -2.1% | $531.66 | $533.08 | $522.91 | 832,600 | |
| $535.17 | +10.65 | +2.0% | $527.18 | $537.81 | $521.30 | 1,641,200 | |
| $524.52 | +9.87 | +1.9% | $512.79 | $528.57 | $510.48 | 1,448,600 | |
| $514.65 | +12.70 | +2.5% | $507.89 | $515.74 | $505.00 | 1,230,000 | |
| $501.95 | +2.21 | +0.4% | $500.00 | $505.83 | $499.50 | 1,298,700 | |
| $499.74 | -9.01 | -1.8% | $511.06 | $512.21 | $497.49 | 1,413,000 | |
| $508.75 | +10.25 | +2.1% | $514.91 | $517.68 | $507.21 | 2,262,500 | |
| $498.50 | +13.28 | +2.7% | $490.45 | $502.94 | $487.54 | 2,089,700 | |
| $485.22 | -21.78 | -4.3% | $507.55 | $508.57 | $484.08 | 1,187,300 | |
| $507.00 | -3.08 | -0.6% | $512.44 | $514.80 | $506.00 | 952,700 | |
| $510.08 | +6.83 | +1.4% | $502.11 | $514.90 | $502.06 | 1,480,800 | |
| $503.25 | -2.39 | -0.5% | $503.14 | $507.87 | $498.90 | 1,488,000 | |
| $505.64 | +3.33 | +0.7% | $504.08 | $511.51 | $503.94 | 806,600 | |
| $502.31 | -1.19 | -0.2% | $505.00 | $507.41 | $496.33 | 775,000 | |
| $503.50 | -1.23 | -0.2% | $504.78 | $506.01 | $496.15 | 914,900 | |
| $504.73 | -2.01 | -0.4% | $509.50 | $509.50 | $499.95 | 939,600 | |
| $506.74 | -16.07 | -3.1% | $522.39 | $523.52 | $505.27 | 1,194,400 | |
| $522.81 | -3.92 | -0.7% | $525.26 | $529.72 | $522.74 | 1,146,000 | |
| $526.73 | -0.94 | -0.2% | $522.22 | $529.46 | $519.25 | 688,800 | |
| $527.67 | +1.48 | +0.3% | $524.27 | $529.89 | $521.16 | 823,500 | |
| $526.19 | +3.81 | +0.7% | $522.55 | $527.69 | $518.92 | 756,200 | |
| $522.38 | +6.04 | +1.2% | $515.56 | $528.99 | $515.30 | 940,900 | |
| $516.34 | +1.35 | +0.3% | $515.60 | $525.43 | $509.56 | 1,213,700 | |
| $514.99 | +4.27 | +0.8% | $521.69 | $525.97 | $508.14 | 1,386,600 | |
| $510.72 | +2.38 | +0.5% | $506.85 | $514.10 | $501.01 | 906,500 | |
| $508.34 | -8.00 | -1.5% | $516.34 | $518.10 | $505.01 | 2,432,900 | |
| $516.34 | +3.08 | +0.6% | $518.35 | $519.07 | $510.20 | 899,600 | |
| $513.26 | -1.37 | -0.3% | $513.80 | $517.95 | $511.35 | 638,200 | |
| $514.63 | -4.88 | -0.9% | $519.94 | $519.94 | $511.00 | 824,800 | |
| $519.51 | +4.07 | +0.8% | $522.17 | $525.29 | $514.66 | 836,900 | |
| $515.44 | +0.88 | +0.2% | $522.10 | $522.10 | $511.81 | 875,500 | |
| $514.56 | -6.56 | -1.3% | $519.13 | $522.60 | $514.32 | 815,000 | |
| $521.12 | -7.78 | -1.5% | $524.00 | $528.17 | $520.08 | 958,300 | |
| $528.90 | -17.22 | -3.2% | $529.64 | $535.00 | $520.20 | 1,121,100 | |
| $546.12 | -11.84 | -2.1% | $549.50 | $556.99 | $544.48 | 803,300 | |
| $557.96 | +1.21 | +0.2% | $559.00 | $560.25 | $551.61 | 800,700 | |
| $556.75 | +9.10 | +1.7% | $552.42 | $558.36 | $549.07 | 1,734,500 | |
| $547.65 | +3.13 | +0.6% | $548.60 | $551.40 | $545.08 | 734,900 | |
| $544.52 | +2.83 | +0.5% | $535.38 | $546.84 | $532.23 | 1,198,300 | |
| $541.69 | -5.86 | -1.1% | $547.09 | $549.57 | $540.08 | 886,900 | |
| $547.55 | +0.26 | 0.0% | $540.08 | $550.83 | $540.08 | 843,900 | |
| $547.29 | -5.56 | -1.0% | $549.84 | $553.47 | $546.24 | 834,100 | |
| $552.85 | +5.26 | +1.0% | $545.53 | $555.69 | $543.75 | 775,000 | |
| $547.59 | -0.46 | -0.1% | $548.98 | $550.62 | $542.42 | 767,400 | |
| $548.05 | +7.79 | +1.4% | $545.10 | $555.32 | $540.70 | 1,074,900 | |
| $540.26 | -11.80 | -2.1% | $543.78 | $548.99 | $538.27 | 1,062,300 | |
| $552.06 | +23.87 | +4.5% | $537.47 | $553.69 | $532.55 | 1,437,300 | |
| $528.19 | +12.64 | +2.5% | $520.00 | $533.78 | $517.34 | 1,497,000 | |
| $515.55 | +9.80 | +1.9% | $503.87 | $517.84 | $502.53 | 1,111,200 | |
| $505.75 | -10.69 | -2.1% | $511.41 | $513.64 | $502.29 | 1,130,500 | |
| $516.44 | -9.29 | -1.8% | $528.68 | $529.00 | $515.74 | 863,500 | |
| $525.73 | -3.92 | -0.7% | $527.00 | $531.22 | $520.08 | 1,047,000 | |
| $529.65 | +5.74 | +1.1% | $525.02 | $532.23 | $522.01 | 1,065,400 | |
| $523.91 | +27.84 | +5.6% | $539.50 | $546.17 | $519.82 | 2,682,200 | |
| $496.07 | +12.04 | +2.5% | $487.11 | $497.40 | $482.10 | 992,400 | |
| $484.03 | -0.80 | -0.2% | $490.91 | $492.40 | $480.86 | 1,015,000 | |
| $484.83 | +6.12 | +1.3% | $487.52 | $491.95 | $479.02 | 1,382,900 | |
| $478.71 | +7.99 | +1.7% | $471.29 | $488.04 | $465.51 | 2,026,400 | |
| $470.72 | -6.38 | -1.3% | $480.00 | $483.36 | $468.14 | 1,510,500 | |
| $477.10 | -4.60 | -1.0% | $480.67 | $480.67 | $469.87 | 957,700 | |
| $481.70 | -1.63 | -0.3% | $474.10 | $482.15 | $470.54 | 1,248,600 |
- Ticker
- Stuttgart:VX1
- Asset type
- Stock
- Sector
- Health care
- Industry
- Pharmaceuticals
- Exchange
- Stuttgart
- Currency
- EUR
What changed lately
Latest news release · Oct 23, 2026
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 2026
Latest earnings call · Aug 3, 2026
Vertex Pharmaceuticals (NASDAQ:VRTX) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Oct 23, 2026
American Society of Nephrology Kidney Week 2026
Conference · 23 slides
Calls
Upcoming
Vertex Pharmaceuticals (NASDAQ:VRTX) Q3 2026 Earnings Call
Mon, Nov 02, 2026 · 4:30 PM ET
Register
Replays
Vertex Pharmaceuticals (NASDAQ:VRTX) Q2 2026 Earnings Call
Mon, Aug 03, 2026 · 4:30 PM ET
Watch TranscriptVertex Pharmaceuticals (NASDAQ:VRTX) Q1 2026 Earnings Call
Mon, May 04, 2026 · 4:30 PM ET
Watch TranscriptVertex Pharmaceuticals (NASDAQ:VRTX) Q4 2025 Earnings Call
Thu, Feb 12, 2026 · 4:30 PM ET
Watch Transcript
Latest news
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 2026
Oct 23, 2026
Closed $523.93 (-2.1%) on Oct 23, 2026
Vertex Appoints Daniel Brennan to its Board of Directors
Oct 20, 2026
Closed $524.52 (+1.9%) on Oct 21, 2026
Vertex to Present New Data on ALYFTREK® at the North American Cystic Fibrosis Conference
Oct 9, 2026
Closed $510.08 (+1.4%) on Oct 9, 2026
Vertex to Announce Third Quarter 2026 Financial Results November 2nd
Oct 7, 2026
Closed $503.25 (-0.5%) on Oct 8, 2026
Vertex Announces Positive Results From Phase 2b AMPLIFIED Study of Inaxaplin in Additional Populations of People With APOL1-Mediated Kidney Disease (AMKD) and Completion of Enrollment in the Phase 2/3 AMPLITUDE Trial
Sep 22, 2026
Closed $514.99 (+0.8%) on Sep 22, 2026
Vertex Partners With World Champion Skier Lindsey Vonn to Raise Awareness of JOURNAVX®, a Non-Opioid Medicine Approved for the Treatment of Moderate-to-Severe Acute Pain
Sep 15, 2026
Closed $514.63 (-0.9%) on Sep 15, 2026
Vertex to Present at the Goldman Sachs Communacopia + Technology Conference
Sep 3, 2026
Closed $557.96 (+0.2%) on Sep 3, 2026
Vertex Completes Acquisition of Crinetics Pharmaceuticals and Announces Expansion of Executive Leadership Team
Sep 1, 2026
Closed $547.65 (+0.6%) on Sep 1, 2026
Quarterly Report for Quarter Ending JUNE 30, 2026 (Form 10-Q)
Aug 4, 2026
Closed $484.83 (+1.3%) on Aug 5, 2026
Vertex Reports Second Quarter 2026 Financial Results
Aug 3, 2026
Closed $478.71 (+1.7%) on Aug 4, 2026
Decks
American Society of Nephrology Kidney Week 2026
Conference · 23 slides · Oct 23, 2026
Q2 2026 Earnings Presentation
Earnings · 21 slides · Aug 3, 2026
Merger or Acquisition (July 2026)
Merger or acquisition · 17 slides · Jul 6, 2026
Q1 2026 Earnings Presentation
Earnings · 19 slides · May 4, 2026
Vertex Pharmaceuticals Incorporated on 6ix
- Sector
- Health care
- Industry
- Pharmaceuticals
- News releases
- 47 in the last 12 months · 276 in all · newest Oct 23, 2026 · oldest 2019
- Calls
- 31 calls with a replay · 31 with a transcript · latest Aug 3, 2026
- Decks
- 20 decks · latest Oct 23, 2026
Where Vertex Pharmaceuticals Incorporated is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:VRTX · Home listing | NASDAQ | United States | USD |
| Xetra:VX1 | Xetra | Germany | EUR |
| gettex:VX1 | gettex | Germany | EUR |
| BCBA:VRTX | BCBA | Argentina | ARS |
| Tradegate:VX1 | Tradegate | Germany | EUR |
| LS Exchange:882807 | LS Exchange | Germany | EUR |
| BMV:VRTX | BMV | Mexico | MXN |
| B3:VRTX34 | B3 | Brazil | BRL |
| Lang & Schwarz:882807 | Lang & Schwarz | Germany | EUR |
| LSE:0QZU | LSE | United Kingdom | USD |
| Frankfurt:VX1 | Frankfurt | Germany | EUR |
| EUROTLX:4VRTX | EUROTLX | Italy | EUR |
| BCBA:VRTXD | BCBA | Argentina | USD |
| Milan:1VRTX | Milan | Italy | EUR |
| VIE:VRTX | Vienna | Austria | EUR |
| BIVA:VRTX | BIVA | Mexico | MXN |
| BOATS:VRTX | BOATS | United States | USD |
| Stuttgart:VX1 · This page | Stuttgart | Germany | EUR |
| Dusseldorf:VX1 | Dusseldorf | Germany | EUR |
| Hanover:VX1 | Hanover | Germany | EUR |
| Munich:VX1 | Munich | Germany | EUR |
| BX Swiss:VX1 | BX Swiss | Switzerland | CHF |
| Aquis:VX1D | Aquis | United Kingdom | EUR |
| BCBA:VRTXC | BCBA | Argentina | USD |
| Hamburg:VX1 | Hamburg | Germany | EUR |
| Aquis:VX1D | Aquis | United Kingdom | EUR |
| Turquoise:VRTXN | Turquoise | United Kingdom | USD |
| BCBA:VRTX.CI | BCBA | Argentina | ARS |
Log in to ask 6ix AI your own questions about Vertex Pharmaceuticals Incorporated.